• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Motif Bio confirms receipt of FDA meeting minutes

    BIOSPACE

    The FDA is forcing a small antibiotic player back to the clinic for a new trial

    ENDPTS

    Motif Bio Receives Complete Response Letter from the FDA

    GLOBENEWSWIRE

    Motif Bio Announces Allowance for 2 Iclaprim Patents with Expiration in 2037

    NASDAQ

    Motif Bio Announces Allowance for U.S. Iclaprim Patents with Expiration in 2037

    DIRECTORSTALK INTERVIEW

    Motif Bio Submits NDA for Iclaprim

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.